Alpoldxaban gastroretentive extended-release formulation (Triastek)
阿哌沙班胃滞留缓释剂（南京三迭纪）
Report date: 2026/05/12 20:00:17
Base Information
Drug NameAlpoldxaban gastroretentive extended-release formulation (Triastek)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Triastek Pharmaceutical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNanjing Triastek Pharmaceutical Technology Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A